Surgical Management of Pediatric Hematologic Disorders

Surgical Clinics of North America

Volumn 86, Issue 2, 2006, Pages 427-439

  Holterman, Ai Xuan L ^a   Adams, Kumari N ^b   Seeler, Ruth A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOGLOBULIN D ANTIBODY; STEROID; THROMBOCYTE ANTIBODY;

ANAPHYLACTOID PURPURA; BLEEDING; CHOLELITHIASIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; HEMATOLOGIC DISEASE; HEMOLYTIC UREMIC SYNDROME; HEREDITARY SPHEROCYTOSIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; SPLENECTOMY; SURGICAL TECHNIQUE; THROMBOCYTE TRANSFUSION;

EID: 33645851962     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2005.12.004     Document Type: Review

References (67)

1. Zimmerhackl L.B. E. coli, antibiotics, and the hemolytic-uremic syndrome. N Engl J Med 342 26 (2000) 1990-1991
2. Siegler R., and Oakes R. Hemolytic uremic syndrome; pathogenesis, treatment, and outcome. Curr Opin Pediatr 17 2 (2005) 200-204
3. Rock G.A. Management of thrombotic thrombocytopenic purpura. Br J Haematol 109 3 (2000) 496-507
4. Karmali M.A. Prospects for preventing serious systemic toxemic complications of Shiga toxin-producing Escherichia coli infections using Shiga toxin receptor analogues. J Infect Dis 189 3 (2004) 355-359
5. Tazzari P.L., Ricci F., Carnicelli D., et al. Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome. Cytometry B Clin Cytom 61 1 (2004) 40-44
6. Caletti M.G., Lejarraga H., Kelmansky D., et al. Two different therapeutic regimes in patients with sequelae of hemolytic-uremic syndrome. Pediatr Nephrol 19 10 (2004) 1148-1152
7. Van Dyck M., and Proesmans W. Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome. Pediatr Nephrol 19 6 (2004) 688-690
8. Loirat C., and Niaudet P. The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol 18 11 (2003) 1095-1101
9. De Petris L., Gianviti A., Giordano U., et al. Blood pressure in the long-term follow-up of children with hemolytic uremic syndrome. Pediatr Nephrol 19 11 (2004) 1241-1244
10. Szer I.S. Henoch-Schonlein purpura. Curr Opin Rheumatol 6 1 (1994) 25-31
11. Saulsbury F.T. Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 78 6 (1999) 395-409
12. Chang W.L., Yang Y.H., Lin Y.T., et al. Gastrointestinal manifestations in Henoch-Schonlein purpura: a review of 261 patients. Acta Paediatr 93 11 (2004) 1427-1431
13. Choong C.K., and Beasley S.W. Intra-abdominal manifestations of Henoch-Schonlein purpura. J Paediatr Child Health 34 5 (1998) 405-409
14. Huber A.M., King J., McLaine P., et al. A randomized, placebo-controlled trial of prednisone in early Henoch Schonlein purpura. [ISRCTN85109383]. BMC Med 2 1 (2004) 7
15. Kawasaki Y., Suzuki J., Sakai N., et al. Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis. Clin Nephrol 60 3 (2003) 153-160
16. Couture A., Veyrac C., Baud C., et al. Evaluation of abdominal pain in Henoch-Schonlein syndrome by high frequency ultrasound. Pediatr Radiol 22 1 (1992) 12-17
17. Connolly B., and O'Halpin D. Sonographic evaluation of the abdomen in Henoch-Schonlein purpura. Clin Radiol 49 5 (1994) 320-323
18. Sonmez K., Turkyilmaz Z., Demirogullari B., et al. Conservative treatment for small intestinal intussusception associated with Henoch-Schonlein's purpura. Surg Today 32 12 (2002) 1031-1034
19. Ioannides A.S., and Turnock R. An audit of the management of the acute scrotum in children with Henoch-Schonlein purpura. J R Coll Surg Edinb 46 2 (2001) 98-99
20. Ben-Sira L., and Laor T. Severe scrotal pain in boys with Henoch-Schonlein purpura: incidence and sonography. Pediatr Radiol 30 2 (2000) 125-128
21. McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol 37 3 (2000) 239-248
22. Chanock S. The etiology of childhood immune thrombocytopenic purpura: how complex is it?. J Pediatr Hematol Oncol 25 Suppl 1 (2003) S7-S10
23. Kaplan R.N., and Bussel J.B. Differential diagnosis and management of thrombocytopenia in childhood. Pediatr Clin North Am 51 4 (2004) 1109-1140 [xi]
24. Bolton-Maggs P.H. Idiopathic thrombocytopenic purpura. Arch Dis Child 83 3 (2000) 220-222
25. Blanchette V.S., and Price V. Childhood chronic immune thrombocytopenic purpura: unresolved issues. J Pediatr Hematol Oncol 25 Suppl 1 (2003) S28-S33
26. Yetman R.J. Evaluation and management of childhood idiopathic (immune) thrombocytopenia. J Pediatr Health Care 17 5 (2003) 261-263
27. George J.N., Woolf S.H., Raskob G.E., et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88 1 (1996) 3-40
28. Butros L.J., and Bussel J.B. Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis. J Pediatr Hematol Oncol 25 8 (2003) 660-664
29. Aronis S., Platokouki H., Avgeri M., et al. Retrospective evaluation of long-term efficacy and safety of splenectomy in chronic idiopathic thrombocytopenic purpura in children. Acta Paediatr 93 5 (2004) 638-642
30. Gadenstatter M., Lamprecht B., Klingler A., et al. Splenectomy versus medical treatment for idiopathic thrombocytopenic purpura. Am J Surg 184 6 (2002) 606-609 [discussion: 609-10]
31. Kumar S., Diehn F.E., Gertz M.A., et al. Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses. Ann Hematol 81 6 (2002) 312-319
32. Eraklis A.J., and Filler R.M. Splenectomy in childhood: a review of 1413 cases. J Pediatr Surg 7 4 (1972) 382-388
33. Read R.C., and Finch R.G. Prophylaxis after splenectomy. J Antimicrob Chemother 33 1 (1994) 4-6
34. Waghorn D.J. Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol 54 3 (2001) 214-218
35. Rescorla F.J., Engum S.A., West K.W., et al. Laparoscopic splenectomy has become the gold standard in children. Am Surg 68 3 (2002) 297-301 [discussion: 301-2]
36. Pace D.E., Chiasson P.M., Schlachta C.M., et al. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura (ITP). Surg Endosc 17 1 (2003) 95-98
37. Kercher K.W., Matthews B.D., Walsh R.M., et al. Laparoscopic splenectomy for massive splenomegaly. Am J Surg 183 2 (2002) 192-196
38. Tarr P.I. Basic fibroblast growth factor and Shiga toxin-O157:H7-associated hemolytic uremic syndrome. J Am Soc Nephrol 13 3 (2002) 817-820
39. El-Alfy M.S., El-Tawil M.M., and Shahein N. 5- to 16-year follow-up following splenectomy in chronic immune thrombocytopenic purpura in children. Acta Haematol 110 1 (2003) 20-24
40. Shah S., and Vega R. Hereditary spherocytosis. Pediatr Rev 25 5 (2004) 168-172
41. Bolton-Maggs P.H., Stevens R.F., Dodd N.J., et al. Guidelines for the diagnosis and management of hereditary spherocytosis. Br J Haematol 126 4 (2004) 455-474
42. Rutkow I.M. Twenty years of splenectomy for hereditary spherocytosis. Arch Surg 116 3 (1981) 306-308
43. Eber S.W., Armbrust R., and Schroter W. Variable clinical severity of hereditary spherocytosis: relation to erythrocytic spectrin concentration, osmotic fragility, and autohemolysis. J Pediatr 117 3 (1990) 409-416
44. Tchernia G., Delhommeau F., Perrotta S., et al. Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis. Hematol J 1 3 (2000) 146-152
45. Bader-Meunier B., Gauthier F., Archambaud F., et al. Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis. Blood 97 2 (2001) 399-403
46. Stoehr G.A., Stauffer U.G., and Eber S.W. Near-total splenectomy: a new technique for the management of hereditary spherocytosis. Ann Surg 241 1 (2005) 40-47
47. de Buys Roessingh A.S., de Lagausie P., Rohrlich P., et al. Follow-up of partial splenectomy in children with hereditary spherocytosis. J Pediatr Surg 37 10 (2002) 1459-1463
48. Marchetti M., Quaglini S., and Barosi G. Prophylactic splenectomy and cholecystectomy in mild hereditary spherocytosis: analyzing the decision in different clinical scenarios. J Intern Med 244 3 (1998) 217-226
49. Sandler A., Winkel G., Kimura K., et al. The role of prophylactic cholecystectomy during splenectomy in children with hereditary spherocytosis. J Pediatr Surg 34 7 (1999) 1077-1078
50. Chui D.H., and Dover G.J. Sickle cell disease: no longer a single gene disorder. Curr Opin Pediatr 13 1 (2001) 22-27
51. Quinn C.T., and Miller S.T. Risk factors and prediction of outcomes in children and adolescents who have sickle cell anemia. Hematol Oncol Clin North Am 18 6 (2004) 1339-1354 [ix]
52. Schnog J.B., Duits A.J., Muskiet F.A., et al. Sickle cell disease; a general overview. Neth J Med 62 10 (2004) 364-374
53. Atweh G.F., DeSimone J., Saunthararajah Y., et al. Hemoglobinopathies. Hematology (Am Soc Hematol Educ Program) 1 (2003) 14-39
54. Hankins J., Jeng M., Harris S., et al. Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome. J Pediatr Hematol Oncol 27 3 (2005) 158-161
55. Gaziev J., and Lucarelli G. Stem cell transplantation for hemoglobinopathies. Curr Opin Pediatr 15 1 (2003) 24-31
56. Reed W., and Vichinsky E.P. Transfusion therapy: a coming-of-age treatment for patients with sickle cell disease. J Pediatr Hematol Oncol 23 4 (2001) 197-202
57. Firth P.G., and Head C.A. Sickle cell disease and anesthesia. Anesthesiology 101 3 (2004) 766-785
58. Griffin T.C., and Buchanan G.R. Elective surgery in children with sickle cell disease without preoperative blood transfusion. J Pediatr Surg 28 5 (1993) 681-685
59. Vichinsky E.P., Haberkern C.M., Neumayr L., et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med 333 4 (1995) 206-213
60. Wales P.W., Carver E., Crawford M.W., et al. Acute chest syndrome after abdominal surgery in children with sickle cell disease: is a laparoscopic approach better?. J Pediatr Surg 36 5 (2001) 718-721
61. Delatte S.J., Hebra A., Tagge E.P., et al. Acute chest syndrome in the postoperative sickle cell patient. J Pediatr Surg 34 1 (1999) 188-191 [discussion: 191-2]
62. Haberkern C.M., Neumayr L.D., Orringer E.P., et al. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood 89 5 (1997) 1533-1542
63. Al-Salem A.H., and Qaisruddin S. The significance of biliary sludge in children with sickle cell disease. Pediatr Surg Int 13 1 (1998) 14-16
64. Al-Salem A.H., and Nourallah H. Sequential endoscopic/laparoscopic management of cholelithiasis and choledocholithiasis in children who have sickle cell disease. J Pediatr Surg 32 10 (1997) 1432-1435
65. Al-Salem A.H. Should cholecystectomy be performed concomitantly with splenectomy in children with sickle-cell disease?. Pediatr Surg Int 19 1-2 (2003) 71-74
66. Gill F.M., Sleeper L.A., Weiner S.J., et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood 86 2 (1995) 776-783
67. Owusu-Ofori S., and Riddington C. Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease. Cochrane Database Syst Rev 4 (2002) CD003425